Search research articles
Contact Us
Filters
Showing results (351-360 of 476) with videos related to
Page
of 48
Sort By:
Mechanisms of Ageing and Development
|
November 23, 2000
A cell kinetic analysis of human umbilical vein endothelial cells
L Kalashnik, C J Bridgeman, A R King, et al.
BMJ (Clinical Research Ed.)
|
June 10, 1995
Dornase alfa for cystic fibrosis. Patients should not be denied a safe, effective treatment
A Bush, M E Hodson, D M Geddes, et al.
Human Molecular Genetics
|
February 1, 1994
Congenital adrenal hyperplasia caused by a novel homozygous frameshift mutation 273 delta AA in type II 3 beta-hydroxysteroid dehydrogenase gene (HSD3B2) in three male patients of Afghan/Pakistani origin
J Simard, E Rhéaume, J F Leblanc, et al.
International Journal of Antimicrobial Agents
|
April 18, 2013
Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drains
Syamhanin Adnan, Janice Xuanhui Li, Steven C Wallis, et al.
Antimicrobial Agents and Chemotherapy
|
October 20, 2020
Cerebrospinal Fluid Penetration of Ceftolozane-Tazobactam in Critically Ill Patients with an Indwelling External Ventricular Drain
Fekade B Sime, Melissa Lassig-Smith, Therese Starr, et al.
Biochemical Society Transactions
|
April 1, 1987
Human apolipoprotein B: complete cDNA sequence and identification of structural domains of the protein
J Scott, R J Pease, L M Powell, et al.
Antimicrobial Agents and Chemotherapy
|
July 31, 2019
Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction
Fekade B Sime, Melissa Lassig-Smith, Therese Starr, et al.
The International Journal of Artificial Organs
|
September 10, 2015
Can we use an ex vivo continuous hemofiltration model to describe the adsorption and elimination of meropenem and piperacillin?
Janattul-Ain Jamal, Andrew A Udy, Steven C Wallis, et al.
Biochemical Society Symposium
|
January 1, 1987
Apolipoprotein B gene: plasma cholesterol and atherosclerosis
J Scott, R J Pease, L M Powell, et al.
Antimicrobial Agents and Chemotherapy
|
October 30, 2019
A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
Fekade B Sime, Melissa Lassig-Smith, Therese Starr, et al.
Page
of 48
Search research articles
Search
Showing results (351-360 of 476) with videos related to
Sort By:
Page
of 48
Mechanisms of Ageing and Development
|
November 23, 2000
A cell kinetic analysis of human umbilical vein endothelial cells
L Kalashnik, C J Bridgeman, A R King, et al.
BMJ (Clinical Research Ed.)
|
June 10, 1995
Dornase alfa for cystic fibrosis. Patients should not be denied a safe, effective treatment
A Bush, M E Hodson, D M Geddes, et al.
Human Molecular Genetics
|
February 1, 1994
Congenital adrenal hyperplasia caused by a novel homozygous frameshift mutation 273 delta AA in type II 3 beta-hydroxysteroid dehydrogenase gene (HSD3B2) in three male patients of Afghan/Pakistani origin
J Simard, E Rhéaume, J F Leblanc, et al.
International Journal of Antimicrobial Agents
|
April 18, 2013
Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drains
Syamhanin Adnan, Janice Xuanhui Li, Steven C Wallis, et al.
Antimicrobial Agents and Chemotherapy
|
October 20, 2020
Cerebrospinal Fluid Penetration of Ceftolozane-Tazobactam in Critically Ill Patients with an Indwelling External Ventricular Drain
Fekade B Sime, Melissa Lassig-Smith, Therese Starr, et al.
Biochemical Society Transactions
|
April 1, 1987
Human apolipoprotein B: complete cDNA sequence and identification of structural domains of the protein
J Scott, R J Pease, L M Powell, et al.
Antimicrobial Agents and Chemotherapy
|
July 31, 2019
Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction
Fekade B Sime, Melissa Lassig-Smith, Therese Starr, et al.
The International Journal of Artificial Organs
|
September 10, 2015
Can we use an ex vivo continuous hemofiltration model to describe the adsorption and elimination of meropenem and piperacillin?
Janattul-Ain Jamal, Andrew A Udy, Steven C Wallis, et al.
Biochemical Society Symposium
|
January 1, 1987
Apolipoprotein B gene: plasma cholesterol and atherosclerosis
J Scott, R J Pease, L M Powell, et al.
Antimicrobial Agents and Chemotherapy
|
October 30, 2019
A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
Fekade B Sime, Melissa Lassig-Smith, Therese Starr, et al.
Page
of 48